Zymride M2 Tablet PR: A Combination Treatment for Blood Sugar Management

Zymride M2 Tablet PR contains a combination of Glimepiride (2mg) and Metformin (500mg). This tablet provides targeted action to help manage blood glucose levels in individuals with type 2 diabetes.

Glimepiride is a sulfonylurea medication that stimulates insulin secretion from the pancreas. It helps lower fasting and postprandial blood glucose levels by increasing insulin sensitivity.
Metformin, a biguanide drug, exerts its effect on multiple sites within the body to improve insulin sensitivity and reduce hepatic glucose production.

Zymride M2 Tablet PR is designed for once-daily administration and offers convenient patient compliance with a sustained-release formulation. It is critical for individuals with type 2 diabetes to follow their healthcare provider's prescribed regimen for optimal blood sugar management.

Please note: This product information is intended for general knowledge and should not be considered medical advice. Consult your doctor or pharmacist for personalized recommendations and medication guidance.